Unknown Manufacturer
Lestaurtinib inhibits autophosphorylation of FMS-like tyrosine kinase 3 (FLT3), resulting in inhibition of FLT3 activity and induction of apoptosis in tumor cells that overexpress FLT3.
Investigated for use/treatment in pancreatic cancer, prostate cancer, and leukemia (myeloid).
